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THE POTENTIAL VALUE of heterologous anti- characterized for toxicity and antibody con- 
lymphoid serum as an immunosuppressive tent, and rendered to globulin as fully de- 
I agent has been known for a number of years. scribed elsewhere (4). The test organs in the 
I However, the first reference to testing of canine experiments were the kidney and 
I antiserums for homograft protection was by liver. The clinical patients had renal ho- 
I Woodruff, who later published with Ander- motransplantation. 
son (20, 21) detailed observations of the 
I effect of these agents used alone or in corn- 
I bination with thoracic duct drainage. Sub- Canine experiments. One hundred and 
sequent valuable studies have been con- &my-four mongrel dogs weighing 10 to 25 
tributed by Waksman, Gray (2), Monaco kilograms were immunized against hepatitis 
(9, 10) and their respective associates and by and distemper and used as homograft re- 
Jeejeebhoy, Nagaya and Sieker, and Levey cipients. Operations were performed under 
and Medawar (6, 7). The experimental sodium pentobarbital anesthesia combined 
model for the foregoing experiments con- with the tranquilizer phencyclidine hydro- 
sisted of skin grafting in mice, rats, or guinea chloride. Renal transplants were accom- 
pigs which were treated with antiserums plished by transferring the donor kidney to 
raised in rabbits. Except for our own brief the contralateral recipient iliac fossa, with 
report (14) and those of Abaza, and Mitchell anastomoses of the renal artery to the proxi- 
and their colleagues there are no published mal end of the cut common iliac artery, the 
accounts on the use of antilymphoid serum renal vein to the side of the common iliac I 
for the protection of whole organ homo- vein, and the ureter to the bladder. Bilateral 
recipient nephrectomy was always carried I 
The present study is a further evaluation out. Orthotopic hepatic transplants were I 
of the importance of this kind of immuno- performed as previously described (15). Be- I 
suppressive therapy for the protection of fore and after both kinds of homotransplan- I 
whole organ homografts in dogs, as well tation, blood urea nitrogen, serum bilirubin, 
as an account of its subsequent application alkaline phosphatase, serum glutamic oxal- I 
in humans. Antiserums against the lymphoid acetic transarninase, serum glutarnic pyruvic I 
tissue of both species were raised in horses, transaminase, and complete hematologic I 
studies were obtained at frequent intervals. I 
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light microscopy. In a number of experi- The leukoagglutinating titer of the recon- 
ments, biopsies were taken at varying in- stituted injectate was 1 :512 to 1 :1,024. The 
tervals after transplantation and examined subcutaneous dose schedule was 0.2 to 0.5 
both with light and electron microscopy. milliliter per kilogram per day. The effec- 
Antilymphoid plasma.-The 3 kinds of tiveness of immunosuppression was eval- 
antilymphoid agents were obtained from im- uated both with renal and orthotopic liver 
munized horses as described previously (4). homotransplantation. 
The first was unabsorbed antilymphoid For 25 kidney transplantations pretreat- 
plasma with a leukoagglutinin titer of 1 :16 ment of 7 to 13 days was provided for 12, 
to 1 :256. The dose of 1 to 4 milliliters per and therapy was begun on the day of opera- 
kilogram was given intraperitoneally every tion in the other 13. In 4 of 9 dogs receiving 
1 to 3 days for 5 to 30 days before renal ho- liver grafts therapy was started on the day 
motransplantation and by a similar schedule of transplantation, and the other 5 had 5 
during the first 20 or 30 postoperative days. to 26 days of pretreatment. In the recipients 
After this time, the intervals between in- of both kidney and liver homografts, therapy 
jections were increased to 4 to 30 days or was stopped from 35 to 60 days after trans- 
therapy was stopped. The plasma was toxic. plantation. 
Of 36 dogs entered into tlie experiment, 1 1 Another 4 dogs received renal homotrans- 
died before operation. Twelve of the remain- plantation after pretreatment for 60 days. 
ing 25 definitive test animals had thym- No postoperative therapy was given to these 
ectomy 7 to 20 days before institution of animals. 
plasma therapy. Antilymphoid globulin and azathioprine. 
Antilymphoid serum. -The second prod- -Crude globulin was given to 14 dogs, be- 
uct tested was antilymphoid serum with a ginning on the day of operation. Postopera- 
titer of 1 :32 to 1 : 128. This was obtained from tively, 1 milligram per kilogram per day 
4 of the same horses, but it was prepared azathioprine was added. 
from coagulated blood and partially ab- Control studies.-The survival of non- 
sorbed against 10 per cent dog red cell pack. treated control animals previously reported 
Six dogs received renal homotransplantation from our laboratory was 11.3 + 4.6 stan- 
with a comparable intraperitoneal dose dard deviation (SD) days after renal ho- 
schedule as that d'escribed for plasma. In motransplantation (14) and 7.1 f 2.2 (SD) 
addition, 6 other animals received kidneys days after orthotopic liver transplantation 
with intraperitoneal antiserum therapy start- (1 5). New control animals were prepared for 
ing on the day of transplantation. the present study with 7 renal and 10 or- 
The same antilymphoid serum was given thotopic liver transplantations. The results 
intraperitoneally to 9recipientsoforthotopic were not different from those in the older 
liver homografts, beginning 1 to 26 days series for which reason both old and new 
before operation. One of the pretreated dogs groups were combined for statistical com- 
received no further therapy after transplan- parison with the results using antilymphoid 
tation, but the others had additional post- therapy. 
operative injections. Four other control animals were treated 
Antilymphoid globulin.-The third kind for 30 days with crude globulin prepared 
of antilymphoid agent tested was crude from the serum of nonimmunized horses. 
globulin which was precipitated from im- The dose of protein was the same, approxi- 
mune horse serum with ammonium sul- mately 30 milligrams per kilogram per day, 
fate after absorption of the serum with dog as with the globulin from immunized horses. 
red cells, and in some instances with dog Renal homotransplantation was then per- 
serum, kidney, and liver. Many ofthe batches formed, and the subcutaneous globulin ad- 
used were concentrated by lyophilization. ministration continued daily until death. 
\ 
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Renal homotransplantation was per- Eight patients with terminal renal failure 
formed in 7 dogs treated only with 1 milli- were treated with immune globulin. In 7, 
gram per kilogram per day azathioprine. the horse globulin was given for 5 or 6 days 
Data comparison.-The various opera- in advance of renal homotransplantation 
tions were performed over a period of al- as well as postoperatively. In the eighth pa- 
most 1% years with variable periods of tient, pretreatment was for 35 days. After 
available follow-up. In order to avoid bias operation, injections were continued daily 
in the event of unusually long survival and to for 1 to 2 weeks, then every other day for 
allow comparison of series studied at dif- 2 to 3 weeks, and finally reduced to twice 
ferent times, credit for survival of any ani- a week until the fourth month after which 1 
ma1 was limited to 70 days. injection per week was given. Two of these 
The variously tested antilymphoid sub- patients had transthoracic thymectomy prior 
stances differed in their titer, degree of puri- to transplantation. All 8 kidneys were ob- 
fication, and extent of absorption with tis- tained from blood relatives. There were 2 
sues or red cells from the lymphoid donor mothers and 6 siblings. The donor and re- 
species. Therefore, an effort was made to cipient ages ranged from 21 to 45 and from 
relate the results by means of a unit system 16 to 36 years respectively. 
which was based upon leukoagglutinating In contrast to the animal experiments, 
titers of these different agents. If 1 milliliter horse globulin was never used as the sole 
of either horse plasma, horse serum, or immunosuppressive agent. Azathioprine was 
crude horse globulin had a titer of 1:128, started on the day of operation and con- 
it was said to contain 128 units. With a titer of tinued thereafter in daily doses of 5.2 to 0.5 
1 : 1,024, 1 milliliter was considered to con- milligram per kilogram per day. During the 
tain 1,024 units. It is recognized that such first month, prednisone was added if needed 
a unit nomenclature is arbitrary and that for control of rejection. After this time, when 
the therapeutic efficacy may not be directly the antilymphoid globulin therapy was be- 
related to the titer as the system implies. ing reduced, prednisone was started in doses 
Clinical studies. Twelve patients have been of 0.3 to 0.67 milligram per kilogram per 
given intramuscular antihuman immune day for patients who had not had rejection. 
globulin which was prepared from the serum Actinomycin C in intravenous doses of 400 
of horses immunized with the lymph nodes, micrograms and local homograft irradiation 
thymuses, and spleens of fresh cadavers (4). were used irregularly if and when rejection 
After absorption of the horse serum with occurred. 
human red cells and serum, precipitation To evaluate the effect of the globulin ther- 
with ammonium sulfate, and lyophilization, apy, comparisons were made with com- 
the reconstituted product had a leukoag- parable patients treated in the past a t  the 
glutinin titer of from 1 :8,192 to 1 : 16,384. University of Colorado in whom survival of 
The single doses of 4 milliliters provided 450 at least 63 days had been attained. The 
to 2,100 units per kilogram. The protein control patients of intrafamilial homotrans- 
content was 7 to 9 grams per cent. The de- plantations were divided into 3 groups of 
velopment of human antibodies against 25, 13, and 22 each. The first series of re- 
horse protein was monitored serially with cipients, treated in 1962 and 1963, had re- 
precipitin tests. The titers of hemagglutinins ceived azathioprine only until the onset of 
against sheep red blood cells were also fol- rejection at which time prednisone was 
lowed, and intradermal skin tests with 0.1 added. The second group received high 
milliliters injectate were performed every 2 dose steroid therapy from the day of opera- 
weeks. The response to antilymphoid glob- tion onward in addition to azathioprine. 
ulin of nontransplanted uremic individuals The third group differed in that smaller 
is described elsewhere (4). quantities of prednisone, usually 0.5 milli- 
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gram per kilogram per day, were started 
on the day of operation. This steroid dose 
was increased only when required to treat 
rejection. In all 3 groups, attempts were 
later made to reduce the prednisone dosage 
as rapidly as possible. Since inclusion in the 
control groups was contingent upon survival 
for 63 days, unfavorable patients were auto- 
matically eliminated. Thus 7, 1, and 3 pa- 
tients who were unsuccessfully treated with 
the respective protocols for less than this 
period were excluded. An additional pa- 
tient in group 2 died on the last day but 
is included. 
Lymphocyte antigens were analyzed by 
Terasaki and his associates in the donors and 
recipients from the 3 control groups as well 
as the antilymphoid series. This information 
became available retrospectively in 21 of the 
25 patients of group 1 and 10 of the 13 pa- 
tients in group 2. I t  was obtained prospec- 
tively for all patients of group 3 and of the 
antilymphoid series. In the last series, there 
were good, average, and poor matches in 3, 
3, and 2 patients respectively. Statistical com- 
parison performed by Terasaki revealed no 
significant differences in the quality of anti- 
gen compatibility among the donor-recipient 
combinations in 4 groups. 
For each of the 3 control groups and for 
the antilymphoid series, the events in the 
first 63 postoperative days were compared by 
determining the average daily blood urea 
nitrogen, creatinine, creatinine clearance, 
white blood count, lymphocyte differential, 
lymphocyte count, azathioprine dose, and 
prednisone dose. From these data it could be 
determined if the function in the antilym- 
phoid patients was as good as in the previous 
series, if this function had been achieved with 
greater or smaller doses of standard imrnuno- 
suppressive agents, and if there were con- 
sistent differences in the peripheral white cell 
differential and total counts in the various 
groups. 
Late homograft rejection.-Three pa- 
tients had received maternal, cadaveric, and 
maternal kidneys respectively, 1 1, 7, and 5 
months previously. In each, there was de- 
terioration of renal function when the pred- 
nisone dose was reduced below 1.3, 1.7, and 
1 milligram per kilogram per day, in the first, 
second, and third patients. In each instance, 
4 milliliters of antilymphoid globulin with a 
titer of 1:4,096 to 1:16,384 were instituted 
every other day or twice a week, and the 
prednisone dose was then attenuated. 
Secondary cadaveric homotransplanta- 
tion.-A 23 year old girl with removal of a 
failed homograft 31 months after transplan- 
tation from a nonrelated living donor re- 
ceived 2 cadaveric kidneys 5 and 8 weeks 
later while being treated with antilymphoid 
globulin, azathioprine, and prednisone. The 
first cadaveric homograft which began to ex- 
crete urine after a week was removed as an 
emergency 2 days later because of acute renal 
vein thrombosis. She had a cardiac arrest 
during bronchoscopy and died 8 days after 
placement of the second cadaveric kidney 
which did not function. Since evaluation of 
therapy was impossible under these circum- 
stances, this patient will not be discussed 
further. 
RESULTS 
Canine experiments. Antilymphoid plasma. 
-The 25 dogs treated before and after renal 
homotransplantation with doses of 64 to 512 
units immune plasma had a survival of 28.2 
I f :  22 (SD) days, a significant (p < 0.01) 
improvement over that of controls. The mean 
figures are somewhat lower than those previ- 
ously reported (14) because survival credit 
for any individual animal was limited to 70 
days. The 12 dogs with thymectomy lived for 
26.4 + 22 (SD) days compared to 29.8 f 
24 (SD) days for the other 13, a difference 
which was not significant. Of the 25 animals, 
18, 11, 9, and 6 survived for at least 15, 20, 
30, and 50 days respectively. The 2 longest 
survivors lived for 95 and 144 days. 
During the early postoperative period 
when injections were given every 1 to 3 days, 
the animals lost weight. They usually became 
profoundly anemic, a complication appar- 
ently attributable at least in part to the high 
hemagglutinin titers in the immune plasma 
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FIG. 1. Course of a dog after renal homotransplantation, employing antilymphoid plasma (ALP) 
for immunosuppression. Note the weight loss and anemia caused by both an early and late course 
of therapy. Rejection was slow to occur after cessation of treatment. Note the minimal change in 
the lymphocyte count when the plasma was given during the preoperative period. 
(4). Later when therapy was either reduced transplantation lived 38 days, the others all 
or stopped, renal failure developed, usually died in less than 15 days. Mean survival was 
rather slowly, in the longer surviving animals 12.8 + 12.5 (SD) days, a value which was 
not significantly better than nontreated con- 
Antilymphoid serum. - Weight loss and trols. 
anemia were also observed with intraperi- After orthotopic liver transplantation 5,4, 
toneal antilymphoid serum administrations, 3, and 2 of the 9 animals lived for more than 
but there were no preoperative deaths. The 15, 20, 30, and 50 days respectively. The 
G dogs with renal homotransplantation which mean survival, with a limitation of maxi- 
received both preoperative and postopera- mum survival credit to 70 days for individual 
tive serum in doses of 64 to 512 units sur- dogs, was 26.8 f 26 (SD) days, indicating 
vived 27.2 + 13 (SD) days, a statistically a statistically significant (p < 0.05) pro- 
significant (p < 0.01) immunosuppressive longation of life. Moreover, 2 of the animals 
effect. Five, 4, and 2 animals Iived at least are still alive and in good health after 5 and 
15,20, and 30 days respectively. The longest 6 months. 
survival was 49 days. Two important observations were made 
In contrast, although 1 of the 6 animals in these 2 long-surviving dogs. One animal 
treated beginning at the time of renal homo- received only 6 injections of antilymphocyte 
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FIG. 2. A dog which received an orthotopic liver homograft after 6 intraperitoneal injections of 
antilymphoid serum (Am. No postoperative therapy was ever given. Note that the lymphocyte 
count was little changed. The dog is still alive. 
serum over a 26 day preoperative period. 
After liver transplants tion, no further therapy 
was given. A definite lymphopenic effect was 
not produced (Fig. 2). The second animal, 
which had pretreatment for 1 month, re- 
ceived postoperative serum treatment for 
only 20 days. After stopping therapy, there 
was a striking lyrnphocytosis (Fig. 3), despite 
which overt rejection has not occurred. 
Antilymphoid globulin.-The dogs re- 
ceived 100 to 500 units of globulin subcu- 
taneously. Gradual weight loss was not un- 
common. A few batches of globulin caused 
anemia which developed slowly over a period 
of several weeks, but this was an unusual 
complication. 
The 12 dogs treated both before and for 2 
months after renal homotransplantation had 
a postoperative survival of 22.9 f 23 (SD) 
days, a statistically significant (p < 0.02) 
prolongation of survival. Five, 4, 3, and 3 
animals lived for more than 15, 20, 30, and 
50 days respectively. In contrast, the 13 dogs 
treated only after operation had a reduced 
survival of 14.3 f 7 (SD) days, a prolonga- 
tion which was nevertheless statistically sig- 
nificant (p < 0.05). This group had 4, 2, 1, 
and 0 living animals after 15, 20, 30, and 
50 days. The slow but progressive late rejec- 
tion in the animals treated with globulin 
(Fig. 4) was similar to that described earlier 
in recipients treated with immune plasma or 
serum. 
The 4 dogs which received kidneys after 
60 days of pretreatment but which were not 
treated after operation all died after 9 to 15 
days. Survival was 12 f 3 (SD) days. There 
was no statistically significant difference from 
nontreated controls. 
The immunosuppressive effect after ortho- 
topic liver transplantation was more con- 
sistent (p < 0.01). With limitation of credit 
to a maximum of 70 days for any dog, the 
mean survival was 36 f 30 (SD) days. Five, 
5, 4, and 4 dogs lived for more than 15, 20, 
30, and 50 days respectively. The longest 
survival, in an animal which is still alive, 
has been 120 days. The 5 dogs which received 
therapy both before and after operation did 
not fare better than the 4 treated only after- 
ward. 
As described earlier with immune plasma 
or serum, the production or maintenance of 
lymphopenia was not a prerequisite for po- 
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FIG. 4. Potentiation of canine renal homograft survival with immunosuppression by antidog- 
lymphoid globulin (ALG). Although the lymphocyte differentialt?action was reduced, the total white 
count was increased and the absolute lymphocyte count was higher postoperatively than during 
the control period. The early postoperative anemia was apparently due to operative blood loss. 
Note the slow rejection after cessation of therapy. 
for at least 15, 20, 30, and 50 days respec- 
tively. Thus the doses, although small, had 
a statistically significant immunosuppressive 
effect (p < 0.05). 
Data comparison.-The foregoing data 
were used to ask several questions of poten- 
tial clinical importance. To do this, smaller 
groups were combined into larger series and 
the significance of differences in results were 
subjected to the Student t test. 
Is pretreatment valuable? The 18 animals 
which received either antilymphoid serum 
or globulin both before and after transplan- 
tation had a significantly (p < 0.05) better 
survival than those 19 dogs treated only after 
operation. 
Is combination therapy helpful or harm- 
ful? The survival of the 14 dogs treated post- 
operatively with 1 milligram per kilogram 
per day azathioprine plus immune globulin 
was compared with that of the 7 dogs which 
received the same course of azathioprine 
alone and with that of the 13 dogs which re- 
ceived only postoperative immune globulin. 
Although the results with the two combined 
agents were better than those obtained when 
antilymphoid globulin was used alone in a 
comparable dose schedule, the difference was 
not statistically significant (p < 0.2). Simi- 
larly, the increased survival with the two 
combined agents in comparison with that 
using azathioprine alone was not statistically 
significant. 
Is success easier to attain with liver than 
with kidney transplantation? Survival in the 
18 liver experiments involving antilymphoid 
serum or globulin was significantly better 
(p < 0.05) than in 37 comparable experi- 
ments with renal homotransplantation. The 
comparison has validity since approximately 
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FIG. 5. Variatiom in immunosuppression and renal function during the first 63 
postoperative days in 4 successive groups of patients who received kidneys from 
I blood relatives. Since the blood urea nitrogen and creatinine clearance were not de- termined each day, these were compiIed on a weekly basis. Those in se.ries 4 received 
I adjuvant therapy with antilymphoid globulin. Note the drastic reduction in average prednisone dose which was achieved in these patients without significant loss of 
I renal function. The progressive d i i u t i o n  of azathioprine dosage in the succeeding series is evident. 
half of the recipients in each kind of trans- was a reduction in the degree of cellular in- 
plantation received therapy both before and filtration, the number of cells possessing py- 
after operation, and the other half were only roninophilic cytoplasm, and the incidence of 
treated following operation. mitoses in those homografts fromdogs treated 
Pathologic studies.-Ninety-nine of the with both low doses of azathioprine and anti- 
renal homografts were examined histologi- lymphoid globulin. Two of these 14 kidneys 
cally. In dogs treated with antilymphoid sub- had no evidence of rejection, the only ones 
stances the features of rejection were not dif- completely spared in the entire study. 
ferent from those described by Porter and Similarly, in the 17 hepatic homografts 
his associates after immunosuppression with studied either from autopsy or biopsy speci- 
other antirejection agents. These included mens, the findings were comparable to those 
infiltration with mononuclear cells of which previously reported in dogs protected with 
20 to 80 per cent had pyroninophilic cyto- azathioprine (15). Animals dying before 3 
plasm. Platelet thrombi and intimal fibrous weeks had centrizonal and usually midzonal 
thickening of interlobular and arcuate ar- necrosis, infiltration of mononuclear cells 
teries were common. Fibrinoid necrosis of around the portal tracts and central veins, 
arteriolar and arterial walls was present in and centrilobular cholestasis. The 6 homo- 
half the specimens and glomerular capillary grafts examined after 3 weeks had variable 
basement membrane thickening was found centrilobular hepatocyte atrophy or reticulin 
in 27 per cent. Vascular and glomerular condensation, or even later fibrosis and pro- 
changes were rare in either the controls or liferation of bile ductules in the portal tracts. 
treated dogs with short survival. The only Five of these 6 livers contained mononuclear 
clear difference in the various test groups cells but in 2 of these the numbers were low. 
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FIG. 6. Course of a patient treated before and after renal homotransplantation with antilymphoid 
globulin. No rejection occurred. Note the rises in precipitin and hemagglutinin titers. findings which 
prompted institution of prednisone therapy. These titers subsequently fell. This patient had a good 
antigen match with his sibling donor. 
In all, pyroninophilic cells were sparse. In hepatotoxic agent (15), but conceivably the 
several of these livers, active rejection ap- horse protein could have contributed by the 
peared to have ceased in contrast to the find- synergistic mechanism described by Paro- 
ings in the homografts of the longest surviv- netto and Popper. 
ing animals after renal homotransplantation Clinical studies. New patients.-All 8 re- 
when the histologic appearance suggested cipients are alive with excellent renal func- 
that none of these kidneys was being toler- tion from 9% to 14 weeks after transplanta- 
ated chronically. tion. Their courses during the fist 63 days 
The effect of the antilymphoid products of convalescence are compared to those of 
on the lymphoid tissue, kidneys, and other the 3 earlier groups in Figures 5 and 8. 
recipient organs has been described (4). From 1962 to 1966 a trend to conserva- 
This included myocardial necrosis and tism with the use of azathioprine was noted. 
necrotizing coronary arteritis which were The mean daily dose of 1.92 milligrams per 
also present but in lower incidence in the kilogram in the fourth series differed signifi- 
controlanimals. Dogs whichhad renal homo- cantly from the means of the first and second 
transplantation under antilymphoid therapy (p < 0.01) but not of the third group. A 
alone had hepatic cholestasis or centrizonal significant lineardownward trend (p < 0.01) 
necrosis in an incidence of 10 and 4 per cent was present in all. 
respectively. When azathioprine was also In contrast, the average daily dose of 
given, these figures rose to 77 and 61 per steroids in the 3 control groups remained 
cent. This latter finding was probably largely quite stable despite the effort to change the 
due to the azathioprine which is a known therapeutic protocol. However, the patients 
. . 
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FIG. 7. The course of the only patient who had a moderately severe rejection among the 8 
treated &om the beginning with antilymphoid globulin (ALG). The young woman, who had a 
very poor Tvasaki antigen match with her fraternal donor, required large dosa of steroids which 
may have contributed to the relative lack of response in the precipitin and leukoagglutinin titers. 
in the antilymphoid globulin series received not made during the first 63 days (Fig. 6) in 
greatly reduced quantities of prednisone. 4 of the 8 patients. In 3 others, a mild rejec- 
The average daily dose was 0.72 milligram tion crisis was easily reversed. Only 1 re- 
per kilogram, a statistically significant reduc- cipient had a secondary rise in blood urea 
tion (p < 0.05) compared to 1.58 milligrams nitrogen to over 100 milligrams per cent, re- 
per kilogram in the pooled control series. quiring protracted high dose steroid therapy 
Renal function in all 4 groups was ana- (Fig. 7). These results are compared in Table 
lyzed to determine if the drug reduction de- I with those obtained in the 3 retrospective 
scribed had been at the expense of an in- control series. Only in group 2, in which 
creased homograft injury. When the pooled massive steroid therapy was used from the 
values of blood urea nitrogen, plasma creati- beginning, was there a similar number of 
nine, and creatinine clearance from the 3 patients who escaped early postoperative re- 
control series were compared with those of jection. The comparison with group 3 is 
the fourth, there was no significant-difference particularly important.- The latter patients 
in any of the 3 tested variables. all had prospective antigen-typing studies 
As would be suspected from these data, and were treated from the beginning with 
difficulties of the antilymphoid series with 30 to 60 milligrams per kilogram per day 
rejection were not serious. This diagnosis was prednisone, despite which early rejection oc- 
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I TOTAL WHITE COUNT I LYMPHOCYTE COUNT I LYMPHOCYTE FRACTION 
FIG. 8. Effect of different immunosuppressive regimens upon peripheral white cells. 
The 4 series are in the same order as in Figure 5. Group 4 received adjuvant therapy 
with antilymphoid globulin. The higher average total white cell count in the later 
series was apparently due to greater conservatism with the use of azathioprine. 
The differences in lymphocyte per cents and total counts were not significant. 
curred in 82 per cent, necessitating even 
higher steroid doses. 
Blood changes.-These are shown in Fig- 
ure 8. With succeeding series there was a 
distinct linear rise in the average daily total 
white cell count, probably as the result of 
the increasingly cautious use of azathioprine 
described earlier. Due to the variability of 
the white cell counts, the differences between 
various pairs of groups were statistically non- 
significant. The per cent of lymphocytes in 
the peripheral blood was approximately the 
same in all 4 groups. The average total lym- 
phocyte counts ranged from 1,380 to 1,606 
per cubic millimeter, the highest values be- 
ing from the patients receiving antilymphoid 
globulin (Fig. 8), but the differences were 
not significant. 
Late homograft rejection.-The clinical 
courses in these 3 patients during the iirst 
10 to 13 weeks of antilymphoid globulin 
TABLE I.-INCIDENCE OF REJECTION DURING THE 
FIRST 63 DAYS IN PATIENTS TREATED WITH 
ANTILYMPHOID GLOBULIN AND IN THE 3 RET- 
ROSPECTIVE CONTROL GROUPS 
Per cent 
No. Rejection rejection 
Group 1 ..................... 25 23 92 
Group 2.. .................... 13 7 54 
. . . . . . . . . . . . . . . .  Group 3. . .  22 18 82 
Group 4 (antilymp hoid). . . . . . .  8 4 50 
The reduced number of rejections in group2 waa evidently due to high 
dose prophylactic therapy with predniaane. 
therapy are summarized in Table 11. The 2 
patients who had received kidneys from re- 
lated donors had stabilization of renal func- 
tion despite very drastic decreases in steroid 
therapy. In both instances, previous dose 
adjustments of considerably lesser magnitude 
had resulted in deterioration of function 
(Fig. 9). The pIasma creatinine and the creati- 
nine clearance were not significantly altered 
in one patient, and in the other there was 
slight improvement. There were striking faIls 
in the blood urea nitrogen, which were prob- 
ably at least partially due to decreased pro- 
tein catabolism secondary to the steroid 
withdrawal. 
The third patient, who had a failing ca- 
daveric homograft, also had a decline in 
blood urea nitrogen. Nevertheless, there was 
a measurable further loss of creatinine clear- 
ance with a rise in plasma creatinine during 
the 13 weeks of steroid withdrawal (Table 
11). 
In all 3 patients, the institution of horse 
globulin reduced the lymphocyte fraction of 
the differential count but, because the white 
count was allowed to increase with adjust- 
ments of azathioprine dose, the absolute 
lymphocyte counts were relatively un- 
changed. 
Evidence of serum toxicity. -Fever as well 
as tenderness at the injection site was seen 
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,[* TIME IN DAYS 
in all patients, most severely after the first ute and the 24 hour reading and consisted 
few injections. not only of erythema but also of induration. 
The antihorse-protein precipitin titers rose Four of the 11 patients had a systemic re- 
slightly in all 11 patients. In 10 the maxi- action other than fever. In 1, hives devel- 
mum titer did not exceed 1 : 16 and in the oped. Another became hypertensive for al- 
other it reached 1:32. Five patients had a most an hour. Immediately after injection, 
T precipitin titer which at first rose and then in the other 2 patients hypotension developed later declined despite continuation of injec- which lasted for 5 and 30 minutes and which tions (Fig. 7). was accompanied by air hunger. All 4 pa- l Hemagglutinin titers against sheep red tients recovered without specific therapy and blood cells rose in 8 of 10 patients tested, in each has subsequently received many more 6 instances to 1 :32 or less, and in the other injections without incident. 2 to 1 :256 and- 1512. Secondary declines All patients had- quantitative studies of were documented in 4 patients. urine protein excretion because of recent Skin tests, which were obtained in 10 pa- demonstration in dogs that antilymphoid tients, showed an increased reaction in 7. globulin can cause renal lesions (4). The 3 This was usually evident in both the 30 min- patients treated late already had proteinuria 
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before instituting globulin therapy and could little histologic evidence of continuing injury. 
not therefore be accurately evaluated. None The incompleteness of immunosuppres- 
of the 8 patients treated with globulin from sion with antilymphoid serum was also evi- 
the outset has proteinuria judged by stan- dent in the studies of Abaza and his asso- 
dard laboratory urinalysis. Quantitative ciates with canine renal homotransplanta- 
analysis of 24 hour specimens revealed pro- tion. Using daily intravenous therapy, they 
tein excretion of less than 400 milligrams were able to prolong homograft function in 
per day in each after a follow-up of 2 to 3 6 of 8 dogs, in 4 of which uremia eventually 
months. developed. Maximum survival was 79 days 
after transplantation and 58 days after re- 
DISCUSSION moval of the recipient's own kidneys at a 
Two general conclusions with immediate second stage operation. Using sheep antidog- 
clinical implications seem justified from the lymphoid serum intravenously, Mitchell and 
information now available concerning anti- his colleagues reported only 1 of 8 dogs with 
dog-lymphoid products. First, there is an im- survival of more than 22 days, but that ani- 
portant difference in the response to injec- mal lived for 10 months after simultaneous 
tions of globulin prepared from the serum of homotransplantation and bilateral nephrec- 
immunized as compared to nonimmunized tomy. The consistency of success has thus 
horses. In the former, development of anti- been less than that reported in inbred rodent 
bodies to the foreign protein is markedly re- experiments by several previous investigators 
tarded as measured by the simple and clini- who employed a skin graft test system. 
cally practical precipitin test (4), presumably The foregoing information imposed cer- 
because of the immunosuppressive qualities tain restrictions upon the way in which horse 
of the injectate. The risk of serum sickness antihuman-lymphoid globulin could be clin- 
is undoubtedly thereby reduced, as the ear- ically evaluated. It  was clear that it had to 
lier rodent studies of Gray and associates (3) be used as an adjuvant rather than as the 
and Levey and Medawar predicted. It is not primary immunosuppressive drug. For this 
eliminated, however, since low increases in reason, it became important to know of the 
precipitin titer were often seen in dogs, an physiologic interaction between the antilym- 
observation which may explain the appear- phoid substances and the more conventional 
ance of glomerular lesions after chronic ther- immunosuppressive agents. This was a par- 
apy in a significant number of nontrans- ticularly important question since an earlier 
planted animals as discussed elsewhere (4). hypothesis of Levey and Medawar (6), sub- 
Secondly, although the capacity of the sequently disproved by the same investiga- 
presently available heterologous antilym- tors (7), held that the immunosuppressive 
phoid agents to mitigage rejection of the properties of antilymphoid serum were due 
canine kidney or liver was easily and un- to binding of the heterologous antibodies to 
equivocally demonstrable in the present recipient lymphocytes thereby "blindfold- 
series of transplantations, its effect in an in- ing" and functionally emasculating them. 
dividual experiment was unpredictable and Such a possibility implied that the action of 
weaker than that known to be obtainable antilymphoid substances was dependent 
with optimal doses of azathioprine. Not only upon astabile lymphoid population, and that 
was there a higher incidence of uncontrolled the superimposition of agents which caused 
early rejection but also, even after weeks or a rapid turnover of stem cells might cancel 
months, the renal homografts all had evi- the effect. 
dence of active rejection. I t  is of interest that The canine experiments with antilyrn- 
more consistent early protection of hepatic phoid globulin plus azathioprine were there- 
homografts was observed, and that in some fore critical. I t  was found that the limited 
examined after several months there was but definite prolongation of survival, whicli 
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TABLE 11.-PATIENTS WITH FAILING RENAL HOMOGRAFTS TREATED WITH ANTILYMPHOID GLOBULIN 
DURING STEROID WITHDRAWAL 
Change during 10 to 13 weeks of therapy 
Patlent Monthpostop.  B.U.N., Crcatintnc, Crcatinim clearance, Prednisone, 
Donor ALG starbd mgm. pcr cent mgm. per cent ml./min. mgrn./kgm./day 
Mother 11 80 4 45 2.4 --t 2.4 10 +12 1.3 -+ 0.67 
LD 102 Mother 5 80 4 40 2.3 -+ 1.8 16 4 3 4  1 .O -+ 0.35 
Cadaver 7 115 4 75 3.2 4 7.0 5.5 -+ 3.0 1.7 -+ 0.23 
- 
The changa depicted were over a period of 10 to 13 weeks. 
ALG, Antilymphoid globulin. 
could be achieved with suboptimal therapy performance of thymectomy in some of the 
using either agent, was slightly increased patients herein reported may not, therefore, 
when the 2 were employed together. Al- have been justified. 
though this improvement was not statisti- Another detail worth additional comment 
cally significant, the really important obser- concerns the proper timing for adrninistra- 
vation was that survival was not made worse. tion of the antilymphoid substances. Careful 
Moreover, the extent of histologic damage studies by Levey and Medawar (6) indicated 
was less in those homografts from dogs pro- that 1 or 2 intraperitoneal injections were 
vided with combination therapy. most effective if given 2 days or more after 
There is evidence that antilymphoid sub- skin grafting and that pretreatment was of 
stances can be used to complement the effi- considerably less value. Working with a sim- 
cacy of other immunosuppressive measures. ilar mouse system but with therapy for longer 
The studies which are most relevant to the periods, Monaco and his colleagues (9) found 
clinical protocol finally decided upon were pretreatment to be distinctively advan- 
made by Levey and Medawar (7). They tageous, a conclusion supported by our ca- 
showed a profoundly synergistic effect of nine studies. There is probably no real in- 
adrenal corticosteroids with antilymphoid consistency in these results. Monaco's exper- 
serum, an observation not dissimilar to that iments and those herein reported were not 
of Woodruff and Anderson (20) who com- designed to determine the most important 
bined antilymphoid serum with thoracicduct time to give a single or a limited number of 
drainage in mice. Levey and Medawar (7) injections, but instead to determine if treat- 
have also demonstrated that total body h a -  ment for a number of days before as well as 
diation and immune serum treatment could after transplantation was superior to that 
be used together with benefit, providing the started just before or at the time of operation. 
roentgenotherapy was given before exposure I t  is important to make this distinction, since 
to the antigen. When irradiation was used pretreatment did appear to be of value in 
late, well established skin homografts in the canine experiments and was accordingly 
serum-treated mice were rejected within a made part of the protocol used for patients. 
few days, long before the expected time. There is evidence that the clinical regimen 
The influence of thymectomy upon the ef- developed as a result of these various con- 
fectiveness of antilymphoid serum or globu- siderations has been a t  least of short term 
lin therapy is more controversial. Monaco value. The 8 recipients in the test series did 
and his associates (1 0) and Jeejeebhoy, using not have unusually complete antigen matches 
rabbit antiserums in mice and rats respec- with their donors and did not appear to 
tively, reported far better results when the enjoy other advantages over previously 
thymus had been excised. This could not be treated patients. The 8 patients are well from 
confirmed in our canine studies, nor in those 9% to 14 weeks postoperatively. In each of 
of Levey and Medawar (7) whose mouse ex- the preceding control series there was a 15 
periments closely resembled those of Monaco to 28 per cent mortality rate during the same 
and his associates and of Jeejeebhoy. The period. The quantities of azathioprine and 
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prednisone were appreciably reduced in the In the patients who were treated with 2 
globulin-treated patients during the critical or more drugs in addition to globulin, the 
first 2 months without the sacrifice of renal significance of changes in lymphocyte counts 
function. This was particularly clear, with was even more difficult to interpret, particu- 
calculation of the steroid doses, since the larly when comparing results in the test 
total amounts required in each preceding group with those obtained from earlier series. 
series had been fixed at almost the same In a past clinical study which included many 
level. The significance of these observations patients from the retrospective control groups 
is increased by the fact that data from those (16), it was shown that lymphocytosis in the 
patients in the earlier series who died before post-transplant period could not be corre- 
9 weeks were excluded from the comparative lated with the presence or absence of rejec- 
calculations, thereby introducing a bias tion. There was, however, a direct correla- 
against the antilymphoid group. tion between the quantity of steroids em- 
The influence of the globulin therapy upon ployed and the degree of lymphopenia. This 
the courses of the 3 patients with late-failing important pharmacologic variable was pres- 
homografts is less clear. In 2 of these 3 pa- ent in both our control and test series. Con- 
tients, the doses of prednisone were materi- sequently, more cannot be said than that the 
ally reduced without further evidence of kid- patients treated with antilymphoid globulin 
ney injury. It is probable that renal function had approximately the same number of 
in such patients can be improved little, if at  peripheral lymphocytes as previously treated 
all, by institution of antilymphoid globulin patients who had received more than twice 
injections, but it is possible that residual as much prednisone. 
function can be sustained with considerably Thus far, discussion has been largely con- 
less prednisone. Benefit of this sort would not fined to the considerable body of evidence 
be unexpected even in these patients with supporting the concept that heterologous 
late-failing grafts since Monaco and associ- antilympoid globulins may be useful agents 
ates (9) and Levey and Medawar (7) showed in clinical homotransplantation. It  is impor- 
that antilymphoid serum can erase the immu- tant to emphasize that the extent to which 
nologic memory of presensitized animals. this may be true will be strongly influenced 
The means by which heterologous anti- by further studies of clinical toxicity. It  was 
lymphoid substances mitigate homograft re- mentioned earlier that glomerular lesions 
jection has been discussed elsewhere from the can be produced in normal dogs by chronic 
viewpoint of the pathologic changes they administration of these substances. Biopsyof 
cause in the lymphoid tissues of dogs (4) and the human homografts will be necessary at 
in light of the information recently provided a relatively early time to determine if similar 
by Levey and Medawar (7). Although the lesions are present, even though none of the 
immunosuppressive effect of these agents has patients now has proteinuria. Such histologic 
not been fully explained, the evidence is information will guide a decision for or 
growing that it is contingent upon neither against further therapy in these or future 
lymphopenia nor lymphoid depletion. The patients. 
horse serum or globulin used for dogs and Furthermore,otherfeaturesofthepatients' 
patients of the present study caused lyrnpho- responses to horse protein are not yet clear. 
penia under appropriate conditions of in vivo The modest and often reversible increases in 
testing (4), a fact which is probably of prac- antihorse-precipitin titers have been cited. 
tical importance in deciding whether or not Moreover, the significance of rises in anti- 
a potent product is being used. Nevertheless, sheep red cell agglutinins, which are appar- 
this was often not observed in animals which ently in response to a Forssrnan type antigen 
survived for long periods after either kidney in the horse protein, is not yet known. Al- 
or liver homotransplantation. though life-threatening toxicity has not been 
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observed, this possibility has not yet been previously. After institution of globulin ther- 
excluded. I t  was principally because of this apy in the latter patients, steroid doses were 
consideration that 4 of the 8 patients in the reduced. In 2 of the 3 patients, renal func- 
series of new patients were eventually treated tion stabilized or improved in the ensuing 10 
with low dose steroid therapy even though to 13 weeks, but in the third there has been 
the clinical diagnosis of homograft rejection further deterioration. 
had not been made. The experimental nature of the clinical 
trial has been stressed in light of the un- 
SUMMARY known risk of serious toxicity from the injec- 
Plasma, serum, or globulin were prepared tions of horse protein. This morbidity can 
from the blood of horses which had been im- be completely assessed only with further ob- 
munized with canine lymphoid tissues. The servation and by study of homograft biop- 
respective agents which were rendered pro- sies in those patients now under treatment. 
gressively less toxic by appropriate absorp- Wider clinical trial is not recommended until 
tion and purification procedures were admin- this information has been obtained. 
istered by the intraperitoneal or subcutane- 
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